Background Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …

Background Effective treatment for hepatitis C virus (HCV) in patients coinfected with human
immunodeficiency virus type 1 (HIV-1) remains an unmet medical need. Methods We …

BACKGROUND/AIMS: HIV-infected patients now live longer and often have complications
of liver disease, especially with hepatitis B or C virus coinfection. Limited data are available …

Background: Immunoassays for determining past SARS-CoV-2 infection have not been
systematically evaluated in vaccinated persons in comparison with unvaccinated persons. …

Background Remdesivir is efficacious for severe coronavirus disease 2019 (COVID-19) in
adults, but data in pregnant women are limited. We describe outcomes in the first 86 pregnant …

Hepatitis C virus (HCV) is associated with the B-cell lymphoproliferative disorders mixed
cryoglobulinemia (MC) and non-Hodgkin lymphoma. We have previously reported that HCV + …

Background While people who inject drugs (PWID) are vulnerable to the adverse outcomes
of events like COVID-19, little is known regarding the impact of the current pandemic on …

Importance To achieve hepatitis C elimination, treatment programs need to engage, treat,
and cure people who inject drugs. Objective To compare a low-threshold, nonstigmatizing …

Background. We and others have shown that primary hepatitis C (HCV) infection in men
infected with human immunodeficiency virus (HIV) causes early-onset liver fibrosis; however, …

Importance The COVID-19 pandemic has caused millions of infections and deaths and
resulted in unprecedented international public health social and economic crises. As SARS-CoV-…